Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

New regenerative medicine-based therapies for hair loss look promising but need more clinical validation.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Finasteride use is not clearly linked to an increased risk of male breast cancer.

The document concludes that minoxidil and finasteride are proven for hair growth, herbal remedies show promise, but more research is needed to confirm their effectiveness.

Finasteride can cause muscle pain and high creatine kinase levels, but stopping the medication may resolve symptoms.

Finasteride doesn't affect omeprazole metabolism in Japanese people.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Androgens and androgen receptors are important for metabolic health, affecting how the body uses glucose and fats through mitochondrial function.

Finasteride helps reduce heart issues and improves heart function.

SCF and c-Kit decrease in AGA hair follicles, possibly affecting hair pigmentation and growth.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

Different forms of hair loss drug can improve effectiveness.

Low-level light therapy safely improves hair coverage, thickness, and count in androgenetic alopecia patients.

Men with balding at age 45 had higher IGF-1 and lower IGFBP-3, suggesting these factors might be important in male pattern baldness.

Men with balding at age 45 had higher IGF-1 and lower IGFBP-3 levels, suggesting these factors might influence male pattern baldness.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Sex hormones affect brain injury differently in males and females.

Different stem cells are key for hair growth and health, and understanding their regulation could help treat hair loss.

Visible light can improve skin disorders and hair loss, but more research is needed to understand long-term effects.

Improved hair loss treatment using special particles and surfactants.

Hair loss involves immune responses, inflammation, and disrupted signaling pathways.

Nutraceuticals may improve skin health and protect against aging, but more research is needed on their optimal use and possible health risks.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Smoking and drinking can lower vitamin levels and potentially trigger early hair loss, but overall vitamin levels don't seem to affect hair loss duration.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

Father's finasteride use may affect son's fertility and testicular function.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

The document concludes that personalized treatment, including lifestyle changes and medication, is essential for managing PCOS in teenagers, while also addressing their psychological well-being.